Subfulminant Hepatic Failure

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2011-02-17
Clinical Trial Update: The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure [Phase 3]
Phase 3 trial evaluating the MARS Albumin Dialysis System in patients with fulminant and subfulminant hepatic failure has completed.